A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer.

Glioblastoma, the deadliest brain cancer, may find hope in immunotherapy, offering potential for better outcomes for patients.